TERN — TERNS PHARMACEUTICALS INC

Ownership history in Commodore Capital LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in TERNS PHARMACEUTICALS INC (TERN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.97% (2025 Q4)
Avg. % of fund
2.08%
First filed
2022 Q3
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,475,000 -4,225,000 -74.1% 3.97% $59.6M $40.40
2025 Q3 ADDED 5,700,000 +5,494,130 +2668.7% 2.09% $42.8M $7.51
2022 Q3 INITIATED 205,870 — — 0.20% $1.2M $5.89
% of Fund (quarterly)    TERN price (monthly, adj. close)

Other funds also holding TERN

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 23.9% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 17.48% Vivo Capital, LLC 3Y 7Y 13.96% SUPERSTRING CAPITAL MANAGEMENT LP 9.6% Vestal Point Capital, LP 6.18% Ikarian Capital, LLC 3Y 5.04% Monashee Investment Management LLC 3Y 7Y 4.49% First Turn Management, LLC 4.03% STEMPOINT CAPITAL LP 2.97% Patient Square Capital LP 3Y 2.77%
← Back to Commodore Capital LP Holdings